# ELEVANCE HEALTH INC FORMERLY (ELV) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 036752103
Page URL: https://superinvestorclub.com/stock/ELV
Last updated: 2026-07-08T11:30:33.059Z

## Summary

As of the most recent 13F filing period, ELEVANCE HEALTH INC FORMERLY (ELV) is held by 9 tracked superinvestors with an aggregate position value of $967.4M representing 0138796811223083343152279002201764796450313001275154 shares.

## Top institutional holders (9)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Sequoia Fund](https://superinvestorclub.com/manager/14) | Ruane, Cunniff & Goldfarb | 1387968 | $406.3M | 6.74% | 2026-03-31 |
| 2 | [Glenn Greenberg](https://superinvestorclub.com/manager/36) | Brave Warrior Advisors | 1122308 | $328.6M | 8.13% | 2026-03-31 |
| 3 | [Donald Yacktman](https://superinvestorclub.com/manager/13) | Yacktman Asset Management | 334315 | $97.9M | 1.31% | 2026-03-31 |
| 4 | [Leon Cooperman](https://superinvestorclub.com/manager/235) | Omega Advisors | 227900 | $66.7M | 2.19% | 2026-03-31 |
| 5 | [Richard Pzena](https://superinvestorclub.com/manager/288) | Pzena Investment Management | 220176 | $64.5M | 0.21% | 2026-03-31 |
| 6 | [Tweedy Browne](https://superinvestorclub.com/manager/18) | Tweedy Browne Company | 4796 | $1.4M | 0.11% | 2026-03-31 |
| 7 | [FPA Queens Road](https://superinvestorclub.com/manager/97) | Bragg Financial Advisors | 4503 | $1.3M | 0.04% | 2026-03-31 |
| 8 | [Dodge & Cox](https://superinvestorclub.com/manager/16) | Dodge & Cox | 1300 | $380,575 | 0.00% | 2026-03-31 |
| 9 | [Seth Klarman](https://superinvestorclub.com/manager/7) | Baupost Group | 1275154 | $373,301 | 7.30% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2023-12-31: 2 holders, $182.5M aggregate, 03858211100 shares
- 2024-03-31: 6 holders, $1.72B aggregate, 016458371074685374620154643633401100 shares
- 2024-06-30: 6 holders, $1.73B aggregate, 016331271024071371855122069415861100 shares
- 2024-09-30: 6 holders, $1.65B aggregate, 016414131004533343138119497620491100 shares
- 2024-12-31: 7 holders, $1.88B aggregate, 018212841629977114395334203315389845181100 shares
- 2025-03-31: 11 holders, $2.81B aggregate, 02280159157757011229205784113424682784002009808334145181200246000 shares
- 2025-06-30: 11 holders, $2.23B aggregate, 02287565110965310956553413403264112809002172765883745311300616000 shares
- 2025-09-30: 11 holders, $2.40B aggregate, 0318962418340021448283340900334373216709552034500269613190001300 shares
- 2025-12-31: 10 holders, $3.38B aggregate, 04794445142250612693021251803340900328756216322450031281300 shares
- 2026-03-31: 9 holders, $967.4M aggregate, 0138796811223083343152279002201764796450313001275154 shares

## Recent congressional trades (34)

- 2025-12-29: Markwayne Mullin (Republican-OK) purchase $15,001 - $50,000
- 2025-11-03: Ro Khanna (Democrat-CA) sale $1,001 - $15,000
- 2025-10-27: Michael McCaul (Republican-TX) sale $15,001 - $50,000
- 2025-08-26: Ro Khanna (Democrat-CA) purchase $1,001 - $15,000
- 2025-08-21: Michael McCaul (Republican-TX) sale $1,001 - $15,000
- 2025-08-13: Lisa McClain (Republican-MI) sale $1,001 - $15,000
- 2025-08-05: Gil Cisneros (Democrat-CA) purchase $1,001 - $15,000
- 2025-08-04: Ro Khanna (Democrat-CA) sale $1,001 - $15,000
- 2025-07-25: Ro Khanna (Democrat-CA) sale $1,001 - $15,000
- 2025-07-10: Lisa McClain (Republican-MI) purchase $1,001 - $15,000
- 2025-06-24: Lisa McClain (Republican-MI) purchase $1,001 - $15,000
- 2025-06-16: Michael McCaul (Republican-TX) sale $15,001 - $50,000
- 2025-05-30: Gil Cisneros (Democrat-CA) sale $1,001 - $15,000
- 2025-05-28: Ro Khanna (Democrat-CA) purchase $1,001 - $15,000
- 2025-05-19: Ro Khanna (Democrat-CA) sale $1,001 - $15,000

## Recent insider transactions (0)


## Citation

When citing, use: "ELEVANCE HEALTH INC FORMERLY (ELV) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/ELV), aggregating SEC 13F, Form 4, and congressional disclosures."